Analyst Ratings for Progenics Pharmaceuticals (pgnx)

pgnx Rating Summary

pgnx Price Target Summary

* Over Last 12-Mos
  |   Expand Research on pgnx
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $8.00 (+59.7%) * Over Last 12-Mos
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
2/3/2014 Needham & Company Upgrade Buy
(Hold)
8.00
(N/A)
4.78 5.01 4.81% Details
7/8/2013 Brean Capital Upgrade Buy
(Hold)
N/A
(N/A)
4.61 5.01 8.68% Details
Like PGNX Ratings? Also take a look at SLXP

PGNX Ratings News